Faisal Alghamdi/LinkedIn
Jun 4, 2026, 15:06
Faisal Alghamdi: Iron Overload in Thalassemia Is Preventable – But Prevention Takes More Than Prescribing Drugs
Faisal Alghamdi, Pediatric Hematology and Oncology Consultant at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
“Honored to be invited as a speaker at the 3rd Madinah Hematology Club sponsored by NewBridge pharmaceuticals.
Iron overload in thalassemia is a preventable killer – yet prevention requires more than a prescription.
It demands a united front:clinicians who counsel at every visit, healthcare systems that ensure access, and charitable organizations that leave no patient behind.
Adherence is not the patient’s job.
It’s ours.
To every physician, administrator, and advocate in the room – the gap between what we know and what our patients receive is the problem we must solve together.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy